These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 17599817

  • 21. Low molecular weight heparin in the treatment of puromycin-induced nephrosis.
    Dos Santos AM, de Olveira AV, da Silva Lemos CC, Mandarim-de-Lacerda CA, Bregman R.
    Pathol Res Pract; 2006; 202(3):157-63. PubMed ID: 16492522
    [Abstract] [Full Text] [Related]

  • 22. [The effect of elastase on aminonucleoside nephrosis--on renal vascular system].
    Ono H, Hirabayashi K, Ono Y, Sagiya A, Kanaya H, Iidaka K.
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):783-8. PubMed ID: 1479717
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Competition between polyanions in glomerular binding and renal clearance.
    Burne MJ, Vyas SV, Smit MF, Pratt LM, Comper WD.
    Arch Biochem Biophys; 1997 Apr 15; 340(2):257-64. PubMed ID: 9143329
    [Abstract] [Full Text] [Related]

  • 25. Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis.
    Diamond JR, Karnovsky MJ.
    Ren Physiol; 1986 Apr 15; 9(6):366-74. PubMed ID: 3602582
    [Abstract] [Full Text] [Related]

  • 26. [Study on correlation between aminonucleoside induced experimental focal glomerular sclerosis and mesangial dysfunction in rats (author's transl)].
    Sawaguchi H.
    Nihon Jinzo Gakkai Shi; 1982 Feb 15; 24(2):109-24. PubMed ID: 7098139
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Experimental model of focal sclerosis. II. Correlation with immunopathologic changes, macromolecular kinetics, and polyanion loss.
    Velosa JA, Glasser RJ, Nevins TE, Michael AF.
    Lab Invest; 1977 May 15; 36(5):527-34. PubMed ID: 865080
    [No Abstract] [Full Text] [Related]

  • 29. Effect of increased glomerular permeability on the localization of immune aggregates and protamine-heparin aggregates in the rat.
    Weening JJ, Grond J, Hoedemaeker PJ.
    Lab Invest; 1983 Nov 15; 49(5):619-25. PubMed ID: 6632777
    [Abstract] [Full Text] [Related]

  • 30. Extracellular matrix component mRNA expression in glomeruli in experimental focal glomerulosclerosis.
    Ebihara I, Suzuki S, Nakamura T, Fukui M, Yaguchi Y, Tomino Y, Koide H.
    J Am Soc Nephrol; 1993 Jan 15; 3(7):1387-97. PubMed ID: 8439650
    [Abstract] [Full Text] [Related]

  • 31. Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules.
    Bohrer MP, Baylis C, Robertson CR, Brenner BM, Troy JL, Willis WT.
    J Clin Invest; 1977 Jul 15; 60(1):152-61. PubMed ID: 874080
    [Abstract] [Full Text] [Related]

  • 32. Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat.
    Kimura K, Endou H, Sakai F.
    J Toxicol Sci; 1979 Feb 15; 4(1):1-10. PubMed ID: 480401
    [Abstract] [Full Text] [Related]

  • 33. Effect of TGF-beta1 antisense oligodeoxynucleotide on renal function in chronic renal failure rats.
    Hiong LC, Voon KL, Abdullah NA, Sattar MA, Rahman NA, Khan AH, Johns EJ.
    Acta Pharmacol Sin; 2008 Apr 15; 29(4):451-7. PubMed ID: 18358091
    [Abstract] [Full Text] [Related]

  • 34. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
    Sampaio-Maia B, Moreira-Rodrigues M, Serrão P, Pestana M.
    Nephrol Dial Transplant; 2006 Feb 15; 21(2):314-23. PubMed ID: 16204272
    [Abstract] [Full Text] [Related]

  • 35. Noninvasive microscopic evaluation of the intact living nephrotic kidney.
    Pulver M, Petroll WM, Andrews PM.
    Lab Invest; 1993 May 15; 68(5):592-6. PubMed ID: 8497129
    [Abstract] [Full Text] [Related]

  • 36. Low-molecular-weight dextran sulfate prevents experimental urolithiasis in rats.
    Tostes V, Martinusso CA, Werneck CC, Mourão PA, Cardoso LR.
    Clin Chim Acta; 2004 Mar 15; 341(1-2):147-55. PubMed ID: 14967171
    [Abstract] [Full Text] [Related]

  • 37. Effects of a low-protein diet on glomerular endothelin family gene expression in experimental focal glomerular sclerosis.
    Nakamura T, Fukui M, Ebihara I, Osada S, Takahashi T, Tomino Y, Koide H.
    Clin Sci (Lond); 1995 Jan 15; 88(1):29-37. PubMed ID: 7704997
    [Abstract] [Full Text] [Related]

  • 38. Alterations of glomerular and extracellular glutathione peroxidase levels in patients and rats with focal segmental glomerulosclerosis.
    Chen HC, Guh JY, Lai YH.
    J Lab Clin Med; 2001 Apr 15; 137(4):279-83. PubMed ID: 11283522
    [Abstract] [Full Text] [Related]

  • 39. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy.
    Trachtman H, Del Pizzo R, Valderrama E, Gauthier B.
    Pediatr Nephrol; 1990 Sep 15; 4(5):501-4. PubMed ID: 2242316
    [Abstract] [Full Text] [Related]

  • 40. [Follow-up study of glomerular lesions in aminonucleoside nephrosis].
    Hirabayashi K, Ishitobi F, Takimoto T, Kure N, Iidaka K.
    Nihon Jinzo Gakkai Shi; 1986 Apr 15; 28(4):387-400. PubMed ID: 3747250
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.